PULMONARY HAEMOSIDEROSIS

PULMONARY HAEMOSIDEROSIS was reported 66 times

These drug classes are most commonly taken by patients reporting PULMONARY HAEMOSIDEROSIS:

# Drug Count
0 Alkylating Drug [EPC] 8
1 Corticosteroid [EPC] 7
2 Nonsteroidal Anti-inflammatory Drug [EPC] 7
3 Endothelin Receptor Antagonist [EPC] 6
4 Phosphodiesterase 5 Inhibitor [EPC] 6
5 Purine Antimetabolite [EPC] 6
6 Prostacyclin Receptor Agonist [EPC] 5
7 Benzodiazepine [EPC] 4
8 Atypical Antipsychotic [EPC] 3
9 Platelet Aggregation Inhibitor [EPC] 3
10 Calcineurin Inhibitor Immunosuppressant [EPC] 2
11 Folate Analog Metabolic Inhibitor [EPC] 2
12 Interleukin-1 Receptor Antagonist [EPC] 2
13 Iron Chelator [EPC] 2
14 Amide Local Anesthetic [EPC] 1
15 Amyloid Beta-directed Antibody [EPC] 1
16 Antiarrhythmic [EPC] 1
17 Antimetabolite Immunosuppressant [EPC] 1
18 Antimycobacterial [EPC] 1
19 CD20-directed Cytolytic Antibody [EPC] 1
20 Calcium [EPC] 1
21 Catecholamine [EPC] 1
22 Central Nervous System Stimulant [EPC] 1
23 Ester Local Anesthetic [EPC] 1
24 Factor Xa Inhibitor [EPC] 1
25 Histamine-1 Receptor Antagonist [EPC] 1
26 Histamine-2 Receptor Antagonist [EPC] 1
27 Human Immunoglobulin G [EPC] 1
28 Immunoglobulin G [EPC] 1
29 Interleukin-6 Receptor Antagonist [EPC] 1
30 Methylxanthine [EPC] 1
31 Nitroimidazole Antimicrobial [EPC] 1
32 Non-Standardized Chemical Allergen [EPC] 1
33 Nucleoside Metabolic Inhibitor [EPC] 1
34 Osmotic Laxative [EPC] 1
35 Oxazolidinone Antibacterial [EPC] 1
36 P2Y12 Platelet Inhibitor [EPC] 1
37 Prostacycline Vasodilator [EPC] 1
38 Pyridone [EPC] 1
39 SARS-CoV-2 Nucleotide Analog RNA Polymerase Inhibitor [EPC] 1
40 Thalidomide Analog [EPC] 1
41 Thiazide Diuretic [EPC] 1
42 Tumor Necrosis Factor Blocker [EPC] 1
43 Vasodilator [EPC] 1
44 Vitamin B12 [EPC] 1
45 Vitamin C [EPC] 1
46 Vitamin D [EPC] 1
47 Xanthine Oxidase Inhibitor [EPC] 1
48 alpha-Adrenergic Agonist [EPC] 1
49 beta-Adrenergic Agonist [EPC] 1